Bronchopulmonary Dysplasia: Then and Now
- 18 February 2012
- journal article
- Published by S. Karger AG in Neonatology
- Vol. 102 (1) , 1-8
Abstract
When bronchopulmonary dysplasia (BPD) was first described in 1967, the use of assisted ventilation in neonates was in its infancy. High concentrations of oxygen were implicated, and BPD was equated with ‘pulmonary oxygen toxicity’. The etiologic role of not only oxygen but also peak inspiratory pressures and the duration of exposure to both was emphasized in the 1970s, but BPD remained a dreaded complication of managing respiratory distress syndrome in the 1980s. It was only after exogenous surfactant became commercially available for endotracheal administration that ‘classical’ BPD began to disappear and was replaced by the ‘new’ BPD. ‘Classical’ BPD was seen in more mature preterm infants (>28 weeks’ gestational age) and in its severe form was characterized radiographically by micro- and macrocysts of the lung, lung hyperinflation and flattening of the diaphragms. In contrast, ‘new’ BPD is seen in less mature infants (<28 weeks’ gestational age), has comparatively mild radiographic abnormalities and has been defined as continued oxygen requirement at 36 weeks’ postmenstrual age. Pathologically, ‘classical’ BPD frequently revealed obstructive bronchiolitis and fibrosis of lung parenchyma, whereas ‘new’ BPD demonstrates minimal fibrosis but uniform arrest of development. Herein, factors which may contribute to the etiology of BPD are described, as well as possible preventative and therapeutic strategies.Keywords
This publication has 46 references indexed in Scilit:
- Chorioamnionitis: Important Risk Factor or Innocent Bystander for Neonatal Outcome?Neonatology, 2010
- Target Ranges of Oxygen Saturation in Extremely Preterm InfantsNew England Journal of Medicine, 2010
- Fetal Growth Restriction and Chronic Lung Disease Among Infants Born Before the 28th Week of GestationPediatrics, 2009
- Ola Didrik Saugstad – An Oxygen RadicalNeonatology, 2008
- Caffeine Therapy for Apnea of PrematurityNew England Journal of Medicine, 2006
- Substrate utilization and kinetics of surfactant metabolism in evolving bronchopulmonary dysplasiaThe Journal of Pediatrics, 2005
- Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989
- Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasiaThe Journal of Pediatrics, 1987
- Bronchopulmonary dysplasia: Possible relationship to pulmonary edemaThe Journal of Pediatrics, 1978